Close

Seattle Genetics Inc. (SGEN) Tops Q1 EPS by 1c

May 8, 2012 4:16 PM EDT
Seattle Genetics Inc. (NASDAQ: SGEN) reported Q1 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $48.2 million versus the consensus estimate of $52.33 million.

For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings